Showing results (861-870 of 999) with videos related to
Sort By:
Pageof 100
JAMA Network Open|January 25, 2024
Clonal Hematopoiesis and Incident Heart Failure With Preserved Ejection FractionArt Schuermans, Michael C Honigberg, Laura M Raffield, et al.Circulation|April 1, 2017
Multimodality Strategy for Cardiovascular Risk Assessment: Performance in 2 Population-Based CohortsJames A de Lemos, Colby R Ayers, Benjamin D Levine, et al.Journal of the American Heart Association|December 29, 2023
Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United StatesWilliam S Weintraub, Deepak L Bhatt, Zugui Zhang, et al.Nature Medicine|August 25, 2023
RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohortsGerald F Watts, Christian Schwabe, Russell Scott, et al.Journal of the American Heart Association|February 21, 2023
Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-ITBrian Olshansky, Deepak L Bhatt, Michael Miller, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Basic Science and PathogenesisCassandra O Blew, Michael R Duggan, Dimitrios Tsitsipatis, et al.Nature Medicine|March 6, 2023
Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trialRobert S Rosenson, Daniel Gaudet, Christie M Ballantyne, et al.Hypertension (Dallas, Tex. : 1979)|July 3, 2024
High-Sensitivity Troponin T, NT-proBNP, and Cognitive Outcomes in SPRINTDevin Haney, Yuan Ma, Djhenne Dalmacy, et al.NEJM Evidence|February 6, 2024
RNA Interference Therapy Targeting Apolipoprotein C-III in HypertriglyceridemiaDaniel Gaudet, Peter Clifton, David Sullivan, et al.The Journal of Clinical Endocrinology and Metabolism|August 14, 2020
Plasma Dehydroepiandrosterone Sulfate and Cardiovascular Disease Risk in Older Men and WomenXiaoming Jia, Caroline Sun, Olive Tang, et al.Pageof 100